The latest quarterly stock-based comp is $8.32 Million with a QoQ Growth of +35.92%. Stock-Based Compensation (SBC) is the expense recognized for equity awards (stock options, RSUs) granted to employees. It's a non-cash expense that dilutes existing shareholders.
Q2 FY2026 (2026-06-30).
Reported quarterly stock-based compensation; no daily interpolation. Q2 FY2026 (2026-06-30): $8.32M.
$8.32M
$8.32 Million
Q2 FY2026 · 2026-06-30
+35.92%
vs. $6.12M prior quarter
23
Quarters of data available
| Period | Stock-Based Comp | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $8.32M | +35.92% | +13.17% |
| Q1 FY2026Period end 2026-03-31 | $6.12M | -4.17% | -10.43% |
| Q4 FY2025Period end 2025-12-31 | $6.39M | -9.75% | -5.27% |
| Q3 FY2025Period end 2025-09-30 | $7.08M | -3.73% | +4.01% |
| Q2 FY2025Period end 2025-06-30 | $7.35M | +7.57% | -23.20% |
| Q1 FY2025Period end 2025-03-31 | $6.83M | +1.36% | -31.15% |
| Q4 FY2024Period end 2024-12-31 | $6.74M | -0.91% | -29.30% |
| Q3 FY2024Period end 2024-09-30 | $6.80M | -28.91% | -33.15% |
| Q2 FY2024Period end 2024-06-30 | $9.57M | -3.57% | -3.82% |
| Q1 FY2024Period end 2024-03-31 | $9.92M | +4.09% | +32.30% |
| Q4 FY2023Period end 2023-12-31 | $9.53M | -6.31% | +56.53% |
| Q3 FY2023Period end 2023-09-30 | $10.18M | +2.27% | +84.21% |
| Q2 FY2023Period end 2023-06-30 | $9.95M | +32.65% | +74.35% |
| Q1 FY2023Period end 2023-03-31 | $7.50M | +23.15% | +70.79% |
| Q4 FY2022Period end 2022-12-31 | $6.09M | +10.26% | +458.30% |
| Q3 FY2022Period end 2022-09-30 | $5.52M | -3.21% | N/A |
| Q2 FY2022Period end 2022-06-30 | $5.71M | +29.94% | N/A |
| Q1 FY2022Period end 2022-03-31 | $4.39M | +302.57% | N/A |
| Q4 FY2021Period end 2021-12-31 | $1.09M | N/A | N/A |
| Q3 FY2021Period end 2021-09-30 | $0 | N/A | N/A |
| Q2 FY2021Period end 2021-06-30 | $657.00K | N/A | N/A |
| Q1 FY2021Period end 2021-03-31 | $586.00K | N/A | N/A |
| Q4 FY2020Period end 2020-12-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
